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Abstract: Multicopper oxidases (MCOs) are produced by microscopic and macroscopic fungal species
and are involved in various physiological processes such as morphogenesis, lignin degradation,
and defense mechanisms to stress inducing environmental conditions as well as fungal virulence.
This review will summarize our current understanding regarding the functions of MCOs present
in Saccharomyces cerevisiae and in different human fungal pathogens. Of the two main MCO groups,
the first group of MCOs is involved in iron homoeostasis and the second includes laccases. This review
will also discuss their role in the pathogenesis of human fungal pathogens.
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1. Introduction
Multicopper oxidases (MCOs) are blue copper containing proteins and they generally have
multiple copper atoms (1 to 6) per molecule [1,2]. Diverse enzymes belong to this family of proteins
that include laccases, ferroxidases, ascorbate oxidase, bilirubin oxidase and laccase-like MCOs [3].
MCOs are produced by both prokaryotic as well as various eukaryotic organisms. MCOs consist of
four enzyme families: laccases (EC 1.10.3.2), ascorbate oxidases (EC 1.10.3.3), ferroxidases (EC 1.16.3.1),
and ceruloplasmin (EC 1.16.3.1) [4]. Detailed analyses of 350 different MCOs were used to classify
them in 10 super families, which are: (A) basidiomycete laccases, (B) ascomycete laccases, (C) insect
laccases, (D) fungal pigment MCOs, (E) fungal ferroxidases, (F) fungal and plant ascorbate oxidases,
(G) plant laccase-like MCOs, (H) copper resistance proteins (CopA), (I) bilirubin oxidases, and (J)
copper efflux (CueO) proteins [2]. All MCOs can oxidize aromatic compounds, and can be divided
into two functional classes [5]. The first group consists of laccases and laccase-like enzymes (e.g.,
laccase-like polyphenol oxidases in Arabidopsis thaliana encoded by TT10 gene) [6], favoring oxidation
of organic substrates over metal ions. The second group oxidizes metal ions (Fe (II), Cu (I) and/or Mn
(II)) with high efficiency, and these MCOs are generally referred to as metal oxidases [7]. These enzymes
catalyze oxidation of substrates with a concomitant reduction of molecular oxygen to water. Detailed
spectroscopic and X-ray crystallographic analyses of electronic and geometric structure of the active
site of MCOs reveal that the catalytic center responsible for these reactions is comprised of four or
more copper atoms, leading to three T types which are T1 (blue copper), T2 (normal copper), and T3
(binuclear copper center). Due to the role of Cu in a diverse array of biological oxidation–reduction
reactions as a cofactor, MCOs also have a high redox potential in a wide variety of reactions [8,9].
The substrate undergoes oxidation in the T1 center having the His-Cys-His (characteristic of MCOs)
sequence, where the Cu atom is bound by two histidine residues and one cysteine forming a distorted
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trigonal pyramid structure. The unique structure of the MCO enzymes allows the binding and
reduction of molecular oxygen into water [10]. Most MCOs contain around 500 amino acid residues
and display a β-sheet structure, forming a Greek Key motif [11]. The three main steps of MCO catalytic
mechanisms include: (1) T1 Cu site reduction through the capture of an electron from the oxidized
substrate, (2) electron transfer from the T1 site to the trinuclear Cu cluster, and (3) O2 reduction to two
H2O molecules. Structurally, laccases belong to the group of multicopper blue proteins that contain two
domains, whereas yeast ferroxidases are six domain-containing multicopper blue proteins, similarly to
human ceruloplasmin. An X-ray crystallography study showed that laccases do not undergo drastic
conformational changes after losing their Cu atom, contrary to ceruloplasmin [12].
The influence of several laccases and ferroxidases on pathogenesis has been reported in various
plant pathogenic fungi such as Magnaporthe grisea, Ophiostoma novo-ulmi, Gaeumannomyces graminis,
and Ustilago maydis [13–16]. Ferroxidases present in the plant pathogen Colletotrichum graminicola
complement the growth defect of ferroxidase mutants in Saccharomyces cerevisae [17]. In the white rot
fungus, Phanerochaete chrysosporium, a new class of MCOs has been discovered which is structurally
different from conventional fungal laccases [18]. A recent study also revealed gene duplication events,
the evolutionary history of MCO genes and the importance of horizontal gene transfer in coprophilous
and non-coprophilous fungi [19]. The presence of various MCOs and their importance is also reported
in diverse human fungal pathogens. Specifically, ferroxidases involved in iron oxidation and laccases
involved in pigmentation and their association with virulence have been reported by different research
groups. The focus of the current review is to provide an updated knowledge of ferroxidases in
S. cerevisiae and ferroxidases as well as laccase in different human pathogenic fungi and their role in
iron metabolism and pathogenesis development.
2. Multicopper Oxidases in Saccharomyces cerevisiae
Although not typically pathogenic in humans, studies in S. cerevisiae provide significant insights
into MCOs in virulent fungi. Iron uptake is a two-step process in this species: (1) first, reduction of Fe
(III) by iron reductases in the plasma membrane, followed by (2) the internalization of the Fe (II) products
by either of two Fe (II) uptake systems. The plasma membrane-based Fe (III) reduction is a high-affinity
system with a Km = 0.15 µM that requires FET3 and is induced by low iron concentration. Fet3p is an
essential component of the high-affinity reductive iron assimilation (RIA) pathway in fungi, which
functions in combination with Ftr1p [20]. Fet3p functions similarly to human ceruloplasmin [21–23].
The internalization step is characterized by low affinity (Km = 30 µM) and requires Fet4p, which
is generally active under iron-replete conditions [23]. Surprisingly, the FET3-FET4 double deletion
mutant of this species remains viable; however, it is extremely sensitive to iron limitation. This result
led to the discovery of another ferroxidase in S. cerevisiae, namely FET5. Overexpression of this gene
suppressed the growth defect of the fet3∆/∆- fet4∆/∆ mutant under iron-limited conditions, confirming
that Fet5p also plays a role in iron transport and homeostasis [24]. Fet3p forms a complex with
the iron permease Ftr1p, a transmembrane protein. In S. cerevisiae (likely most fungi and plants),
the extracellular Fe (III) is mobilized after the reduction to Fe (II) by the surface metalloreductase
Fre1p and then oxidized by Fet3p. The oxidized form of Fe (III) is not a substrate of Ftr1p, so the
iron uptake is paired strictly with ferroxidation. This permease-oxidase based transport system in
S. cerevisiae provides a model that explains the copper-iron connection in biology [25,26]. Structural
analysis shows that Fet3p belongs to the family of integral membrane protein (type 1). The N-terminal
catalytic domain of the protein is located on the extracellular side of the plasma membrane and the
single C-terminus transmembrane domain is tethered to the membrane [27]. The detailed 3D structure
of the Fet3p extracellular ferroxidase domain shows a unique characteristic that enables Fe transport
in eukaryotes. This structure also reveals structural differences between Fet3p and laccases [28,29].
Figure 1 schematically summarizes the presence of different MCOs in S. cerevisiae and various human
pathogenic fungi.
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3.1. Candida albicans 
C. albicans is the most frequently isolated species of invasive Candida infections [30]. It is an 
opportunistic pathogenic fungus that is also a member of the healthy human mycobiota. It is able to 
cause both superficial infections of the skin or mucosal surfaces and invasive infections, where the 
fungus can spread to all vital organs through dissemination [31,32]. In order to survive within 
different host niches with restricted amounts of accessible iron, C. albicans has evolved various iron 
uptake mechanisms. Iron is an essential micronutrient for both the host and C. albicans, therefore iron 
uptake during infection also plays a role in the pathogenesis of this fungus [33]. Similar to S. cerevisiae, 
C. albicans has reductive iron uptake machinery and has several genes encoding ferric reductases (17 
putative genes) and five ferroxidases belong to MCO in its genome [34].  
The expression of the five ferroxidases , namely FET3 (orf19.4211), FET31 (orf19.4213), FET33 
(orf19.943), FET34 (orf19.4215), and FET99 (orf19.4212), varies depending on environmental 
conditions, including the availability of iron and oxygen and the presence of antifungals [35–37]. 
Functional characterization of these ferroxidases confirmed their role in iron uptake, morphological 
transition, and pathogenesis. A homozygous deletion mutant of FET31 (referred to as FET3 in the 
publication) showed a growth defect under low iron conditions; however, the mutant strain was as 
Figure 1. Schematic image showing important multicopper oxidases in different fungal species such
as S. cerevisiae, C. albicans, C. glabrata, C. parapsilosis, A. fumigatus, C. neoformans, M. circinelloides,
and H. capsulatum and their function.
3. Multicopper Oxidases and Their Function in Human Pathogenic Budding Yeast
3.1. Candida albicans
C. albicans is the most frequently isolated species of invasive Candida infections [30]. It is an
opportunistic pathogenic fungus that is also a member of the healthy human mycobiota. It is able
to cause both superficial infections of the skin or mucosal surfaces and invasive infections, where
the fungus can spread to all vital organs through dissemination [31,32]. In order to survive within
different host niches with restricted amounts of accessible iron, C. albicans has evolved various iron
uptake mechanisms. Iron is an essential micronutrient for both the host and C. albicans, therefore iron
uptake during infection also plays a role in the pathogenesis of this fungus [33]. Similar to S. cerevisiae,
C. albicans has reductive iron uptake machinery and has several genes encoding ferric reductases
(17 putative genes) and five ferroxidases belong to MCO in its genome [34].
The expression of the five ferroxidases, namely FET3 (orf19.4211), FET31 (orf19.4213), FET33
(orf19.943), FET34 (orf19.4215), and FET99 (orf19.4212), varies depending on environmental conditions,
including the availability of iron and oxygen and the presence of antifungals [35–37]. Functional
characterization of these ferroxidases confirmed their role in iron uptake, morphological transition,
and pathogenesis. A homozygous deletion mutant of FET31 (referred to as FET3 in the publication)
showed a growth defect under low iron conditions; however, the mutant strain was as virulent
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as the wild type strain in a mouse model of systemic candidiasis [38]. CaFET3 and CaFET34 are
important ferroxidases under iron starvation conditions. Specifically, deletion of CaFET33 and CaFET34
decrease the cellular iron content under iron limited conditions, although the mutants do not exhibit a
growth defect. Deletion of CaFET34 also significantly reduces filamentous growth and the virulence
of C. albicans in a mouse model of systemic candidiasis [39]. Fet31p and Fet34p are localized to the
plasma membrane and participate in Fe-uptake by forming a complex with Ftr1p [40]. Interestingly,
CaFET3 has also been associated with fungal prostaglandin E2 production [41].
3.2. Candida parapsilosis
C. parapsilosis is also an opportunistic human fungal pathogen, and depending on the country, it is
the second or third most frequently isolated Candida species in immunocompromised patients with
candidemia [42]. C. parapsilosis accounts for the highest numbers of candidiasis episodes in premature
or low birth weight infants and can exist in diverse environments besides the human mycobiome.
It typically exists in a yeast form, though it can generate pseudohyphae and it avidly forms multidrug
resistant biofilms on abiotic surfaces such as dentures or catheters [42,43]. Although various virulence
factors are associated with this fungus’ pathogenicity, the molecular mechanisms of iron metabolism
and homoeostasis are poorly understood. Recently, however, three putative ferroxidase encoding
genes were identified in its genome, which show high sequence similarity with ScFET3. A study of
gene-deletion strains of CPAR2_603600 (79% identity with CaFET3 and 54% identity with ScFET3)
demonstrated that this gene is required for fungal growth under low iron conditions. The deletion
mutant revealed a marked reduction in pseudohyphae and biofilm formation as well as alterations
in the expression of many orthologous genes potentially involved in iron metabolism regulation
(in press). Unlike in C. albicans, the deletion mutant had attenuated virulence in a mouse model of
systemic candidiasis, suggesting a divergent role in these and possibly other species. Similar to CaFET3,
this gene in C. parapsilosis also plays a role in PGE2 production from externally added arachidonic
acids [44,45].
3.3. Candida glabrata
C. glabrata is also an opportunistic human fungal pathogen and part of the healthy human
mycobiota [46]. C. glabrata is a unicellular budding yeast and phylogenetically closer to S. cerevisiae
than to C. albicans. Approximately 12% of total bloodstream Candida infections globally are caused
by C. glabrata and the mortality rate can reach up to 30% [46–49]. In silico analysis has revealed three
ferroxidase genes, namely CgFET3 (high affinity iron uptake; 70% similarity with ScFET3), CgFET4
(low-affinity ferrous transporter of the plasma membrane; 58% similarity with ScFET4), and CgFET5
(iron storage and utilization; 64% similarity with ScFET5). Phenotypic profiling of the fet3∆/∆ deletion
mutant in C. glabrata revealed that FET3 is required for growth in the presence of the iron chelator
bathophenanthrolinedisulfonic acid (BPS), suggesting that FET3 is a part of the high-affinity iron
uptake system in C. glabrata. The mutant strain is sensitive to oxidative stress and to the antifungal
drug fluconazole, and also displays attenuated growth on media containing sodium chloride (osmotic
stressor), caffeine and congo red (cell wall stressors), and SDS (sodium dodecyl sulfate, membrane
stressor). Comparison of the intracellular iron levels reveals that the iron content of the CgFET3 deletion
mutant is ∼20%–50% lower than wild type cell. Disruption of this gene also resulted in ∼10%–20%
reduction in the mitochondrial aconitase activity, which is a Fe-S containing protein [50]. C. glabrata
is able to grow inside macrophages [51], but the deletion of CgFET3 and CgFET5 reduces this ability.
Fungal burden analysis of the kidneys of mice revealed lower CFUs in mice infected with the mutant
strains compared to the wild type [50]. Hence, FET3 and FET5 regulate the pathogenesis of C. glabrata.
The homologue of an mRNA-degrading protein Cth2 has also been shown to regulate the expression
FET3 in C. glabrata [52,53].
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3.4. Cryptococcus neoformans
Cryptococcosis remains a leading cause of death in the HIV/AIDS population as it is estimated
that there are ~180,000 deaths annually, mostly in sub-Saharan Africa [54,55]. Most of these patients are
either infected with C. neoformans or, to a lesser extent, C. gattii [54]. The two main components of the
C. neoformans high affinity iron uptake system are the iron permease CFT1 and the ferroxidase CFO1.
Both CFT1 and CFO1 are present on chromosome 12 and are divergently transcribed. C. neoformans also
containsCFT2 andCFO2, which encode an iron permease and a ferroxidase, respectively, and are present
on chromosome 3 [56]. Deletion mutants of each revealed that CFO1 is required for high-affinity iron
transport, however, the lack of CFO2 led to no visible growth defect under limited iron conditions [57].
Using a mouse inhalation model of cryptococcosis, the virulence of the cfo1∆/∆, cfo2∆/∆ and the cfo1∆-
cfo2 ∆ double mutants was analyzed. The cfo1∆ single mutant as well as the cfo1∆- cfo2∆ double mutant
showed a significantly attenuated virulence compared to the wild type strain [58]. Similarly to the
equivalent C. glabrata mutants, these mutant strains in C. neoformans were also more susceptible to
fluconazole [58]. A localization study using GFP tagged CFO1 revealed that the protein is localized
to plasma membrane [59]. Interestingly, it has been suggested that the cAMP pathway regulates
the intracellular trafficking of Cfo1p, as a defect in cAMP signaling leads to mis-localization of the
Cfo1-GFP fusion protein [59].
C. neoformans also contains homologues of a laccase encoded by LAC1 and LAC2 expressed from
the same chromosome. Deletion mutants of both the genes show significant reduction in melanin
production [60]. The formation of melanin in the cell wall of this species protects the cell from different
environmental stress conditions and host immune attacks [61]. The deletion mutant of these two genes
also make the cells more susceptible to killing by alveolar macrophages [62]. The LAC1 gene was
also shown to be regulating fungal prostaglandin E2 production [63]. The LAC1 gene also plays an
important role in C. neoformans’ virulence as the mutant with the disrupted gene was not lethal in the
mouse infection model [64].
4. Multicopper Oxidases and Their Function in Other Human Pathogenic Fungi
4.1. Mucor circinelloides
Mucormycosis is an emerging fungal infection threatening mainly immunocompromised patients
suffering from diabetes or cancer or those underwent organ transplantation. The mortality rates of
mucormycosis can reach as high as 90% in disseminated infections, which is a consequence of the lack
of effective treatments and antifungal drug resistance [65–68]. M. circinelloides, a frequently used model
to study mucormycosis, is a dimorphic fungus that can multiply through the formation of branching
coenocytic hyphae under aerobic conditions or spherical multipolar budding yeasts in an oxygen
deprived environment [69]. Three putative ferroxidase genes have been identified that show sequence
similarity with ScFET3: fet3a, fet3b, and fet3c. Under aerobic conditions, only fet3a is expressed during
the yeast phase, while the other two are specifically expressed in mycelia. Gene expression and deletion
analysis of these genes revealed their necessity for growth under iron-limited conditions (media with
iron chelator phenanthroline). Murine experiments with the fet3a∆/∆, fet3b∆/∆ and fet3c∆/∆ strains
revealed that only fet3c significantly impacts virulence [70].
4.2. Histoplasma capsulatum
Histoplasma capsulatum is an intracellular pathogen that is the main cause of histoplasmosis in both
immunocompetent and immunocompromised individuals. Histoplasma is a dimorphic fungus that is
mycelial in nature and a yeast during mammalian disease [71]. Ohio and Mississippi river valleys,
and the southeastern, central, and mid-Atlantic states report the most cases of histoplasmosis, and the
infection rate can reach up to almost 500,000 individuals annually [72]. Although previous in silico
analyses of the H. capsulatum G186AR genome identified orthologues of S. cerevisiae FET3 and FTR1
(sequence similarity: 65% for FET3 and 61% for FTR1, respectively), functional studies have not yet
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been performed. Interestingly, in silico analyses showed that H. capsulatum strain (G217B) lacks the
orthologues of either of these genes in the genome [73,74].
4.3. Aspergillus fumigatus
Invasive aspergillosis is the most common cause of airborne fungal invasive infections among
immunocompromised patients worldwide and is primarily caused by A. fumigatus [75]. Patients with
prolonged neutropenia are particularly susceptible [76]. The mortality rate of invasive aspergillosis
is ~50% and increases in the setting of drug resistant strains [77–80]. Four iron uptake systems have
been described in A. fumigatus: the low affinity ferrous iron uptake system (not yet characterized
at the molecular level), two siderophore mediated high affinity ferric iron uptake systems, and the
reductive iron assimilation system (RIA) [81]. Disruption of sreA, mediating siderophore biosynthesis
in A. fumigatus, results in decreased virulence in mice [82,83]. The three major components of reductive
iron assimilation are the ferric reductase FreB which helps in reduction of ferric to ferrous iron, then
the import of ferrous iron through iron permease FtrA, and finally, oxidation by ferrous to ferric iron
by ferroxidase FetC. FetCp is 52% identical to C. albicans Fet3p and FtrAp is 55% identical to C. albicans
Ftr1p at the amino acid level [81,84] Although FetC is upregulated under iron-restricted conditions in
A. fumigatus, a detailed characterization of this MCO has not been performed yet.
A. fumigatus contains two putative laccase encoding genes, namely Abr1 and Abr2, that are part
of a gene cluster participating in melanin synthesis. The expression of A. fumigatus laccases Abr1/2 is
dependent on hyphal competency and significantly increased during conidiation [85]. The abr2∆/∆
mutant strain showed increased sensitivity to reactive oxygen species and reduced laccase activity in
sporulating mycelia. However, unlike in C. neoformans, Abr2 deletion in A. fumigatus did not show
any reduction in virulence in an intranasal mouse infection model [86]. Previous sequence analyses
showed that the Abr1 protein does not contain the four residues that are present in S. cerevisiae Fet3 for
Fe(II) binding, only the glutamic acid (E185) [87]. This also suggests that they represent a separate
class of MCOs, evolved from an ancient canonical ferroxidase [88]. However, the deletion mutant of
the arp1 gene (regulating melanin production in Colletotrichum lagenarium and Magnaporthe grisea) in
A. fumigatus produced reddish-pink conidia that are more susceptible to complement attack [89].
5. Conclusions
The family of MCOs is one of the most diverse family of enzymes, having a wide variety of
functions. The importance of MCOs and their role in metal homoeostasis is well known in various
human pathogens including bacteria, fungi, and parasites, although their detailed roles in virulence is
still not fully explored. Multicopper oxidases are ubiquitous in the fungal kingdom which shows their
evolutionary importance. In the current review, we aimed to collect all relevant information about
different MCOs present in human fungal pathogens belonging to diverse fungal kingdoms, such as
Ascomycetes, Basidiomycetes, and Zygomycetes. They have evolved different pathogenic mechanisms
to infect human hosts. Our knowledge of the role of iron in fungal pathogenicity has advanced
over recent years, however still little information is available about the precise role and inclusion
of reductive iron uptake systems—including the Fet/Ftr complex—in pathogenicity mechanisms.
For instance, the presence of iron for the human pathogenic Paracoccidioides species also influences
virulence, although no detailed study is available about the MCOs of this particular fungus. Only in
silico analyses suggest that PAAG_06004 and PADG_05994 could encode functional ferroxidases [90].
Laccases also play an important role in fungal pathogens by generating mainly melanin. However, more
research is needed to address why some of the pathogenic fungi evolved a laccase enzyme system with
the reductive iron system. Moreover, the presence of this evolutionary conserved system in pathogenic
fungal species can be a potential target for selective therapeutic intervention in multiple mycoses.
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